Clinical Research Directory
Browse clinical research sites, groups, and studies.
Precision Medicine in the Depression Treatment
Sponsor: Rigshospitalet, Denmark
Summary
The BrainDrugs-D study uses multimodal neuroimaging combined with self-report measures, clinical and molecular markers to identify clinically relevant predictors that can identify subtypes of major depressive disorder (MDD) and, in a naturalistic setting, predict treatment response to standard antidepressive treatment. The cohorts are followed in nationwide health registries.
Official title: The BrainDrugs-Depression Study: A Prospective Precision Psychiatry Cohort Study in the Treatment of Depression
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
800
Start Date
2021-06-15
Completion Date
2026-12
Last Updated
2024-10-08
Healthy Volunteers
No
Conditions
Interventions
Treatment Package for First-Episode Depression
The outpatient 'treatment package' for first episode depression is a national uniform package designed by Mental Health Services in the Capital Region. The treatment package for first-episode depression is a program with manualized group CBT, psychoeducation of patients and relatives, and relapse prevention. Antidepressant medication and individual psychotherapy are available as needed.
Locations (1)
Neurobiology Research Unit, Rigshospitalet
Copenhagen, Denmark